ERBB2 and breast cancer: TILs are observed in breast cancer tissue regardless of histologic and molecular subtypes, but triple-negative breast cancers (TNBC) and human epidermal growth factor 2 (HER2)-positive breast cancers tend to show more prominent TIL infiltration compared to hormone receptor-positive cancers2.